← United States · Coverage record
US · SEC FORM 4
Innoviva, Inc.
INVA · Nasdaq · CIK 0001080014 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
17 Form 4 transaction lines observed in the same window
0 sales · 17 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-06-15 · DENNER ALEXANDER J; Sarissa Capital Management LP.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 6,845,485
- Previous report
- 7,144,265
- Avg daily volume
- 1,209,089
- Days to cover
- 5.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-06-15 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 62,000 | USD 13.13 | USD 814,060 | SEC filing ↗ |
| 2023-06-06 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 8,000 | USD 13.05 | USD 104,400 | SEC filing ↗ |
| 2023-06-05 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 7,000 | USD 13.04 | USD 91,280 | SEC filing ↗ |
| 2023-05-30 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 120,000 | USD 13.01 | USD 1,561,200 | SEC filing ↗ |
| 2023-05-26 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 30,000 | USD 13.12 | USD 393,600 | SEC filing ↗ |
| 2023-05-25 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 50,000 | USD 13.09 | USD 654,500 | SEC filing ↗ |
| 2023-05-19 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 36,000 | USD 13.48 | USD 485,280 | SEC filing ↗ |
| 2023-05-18 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 10,000 | USD 13.05 | USD 130,500 | SEC filing ↗ |
| 2023-05-18 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 10,000 | USD 13.05 | USD 130,500 | SEC filing ↗ |
| 2023-05-17 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 50,000 | USD 13.07 | USD 653,500 | SEC filing ↗ |
| 2023-05-17 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 50,000 | USD 13.07 | USD 653,500 | SEC filing ↗ |
| 2023-05-11 | DENNER ALEXANDER J; Sarissa Capital Management LP | Purchase (P) | Common Stock, par value $0.01 per share | 290,000 | USD 12.34 | USD 3,578,600 | SEC filing ↗ |
| 2023-03-10 | Raifeld Pavel | Purchase (P) | Common Stock | 3,000 | USD 10.87 | USD 32,610 | SEC filing ↗ |
| 2021-05-24 | Bickerstaff George | Purchase (P) | Common Stock | 10,000 | USD 13.46 | USD 134,600 | SEC filing ↗ |
| 2021-05-21 | Bickerstaff George | Purchase (P) | Common Stock | 10,000 | USD 12.97 | USD 129,700 | SEC filing ↗ |
Form 4 evidence
25 transaction lines in the latest 365-day window; 134 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Zhen Marianne | Tax withholding (F) | Common Stock | 1,127 | USD 21.00 | USD 23,667 | SEC filing ↗ |
| 2026-08-20 | Raifeld Pavel | Tax withholding (F) | Common Stock | 1,130 | USD 21.00 | USD 23,730 | SEC filing ↗ |
| 2026-08-20 | Basso Stephen | Tax withholding (F) | Common Stock | 558 | USD 21.00 | USD 11,718 | SEC filing ↗ |
Show recent Form 4 evidence (24 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Zhen Marianne | Tax withholding (F) | Common Stock | 1,127 | USD 21.00 | USD 23,667 | SEC filing ↗ |
| 2026-08-20 | Raifeld Pavel | Tax withholding (F) | Common Stock | 1,130 | USD 21.00 | USD 23,730 | SEC filing ↗ |
| 2026-08-20 | Basso Stephen | Tax withholding (F) | Common Stock | 558 | USD 21.00 | USD 11,718 | SEC filing ↗ |
| 2026-05-20 | Zhen Marianne | Tax withholding (F) | Common Stock | 1,127 | USD 22.24 | USD 25,064 | SEC filing ↗ |
| 2026-05-20 | Raifeld Pavel | Tax withholding (F) | Common Stock | 1,130 | USD 22.24 | USD 25,131 | SEC filing ↗ |
| 2026-05-20 | Basso Stephen | Tax withholding (F) | Common Stock | 559 | USD 22.24 | USD 12,432 | SEC filing ↗ |
| 2026-05-18 | Linden Josephine | Award / grant (A) | Common Stock | 15,194 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-15 | Raifeld Pavel | Award / grant (A) | Common Stock | 1,123 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-15 | Basso Stephen | Award / grant (A) | Common Stock | 1,123 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Zhen Marianne | Award / grant (A) | Common Stock | 12,766 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Small Derek A | Award / grant (A) | Common Stock | 9,786 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Schlesinger Sarah J. | Award / grant (A) | Common Stock | 9,786 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Raifeld Pavel | Award / grant (A) | Common Stock | 126,646 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Haimovitz Jules | Award / grant (A) | Common Stock | 9,786 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | DiPaolo Mark | Award / grant (A) | Common Stock | 9,786 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-04 | Basso Stephen | Award / grant (A) | Common Stock | 37,994 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-20 | Zhen Marianne | Tax withholding (F) | Common Stock | 2,460 | USD 23.39 | USD 57,539 | SEC filing ↗ |
| 2026-02-20 | Raifeld Pavel | Tax withholding (F) | Common Stock | 2,986 | USD 23.39 | USD 69,843 | SEC filing ↗ |
| 2026-02-20 | Basso Stephen | Tax withholding (F) | Common Stock | 1,244 | USD 23.39 | USD 29,097 | SEC filing ↗ |
| 2025-11-20 | Zhen Marianne | Tax withholding (F) | Common Stock | 992 | USD 21.16 | USD 20,991 | SEC filing ↗ |
| 2025-11-20 | Basso Stephen | Tax withholding (F) | Common Stock | 237 | USD 21.16 | USD 5,015 | SEC filing ↗ |
| 2025-11-15 | Basso Stephen | Award / grant (A) | Common Stock | 604 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-03 | Raifeld Pavel | Award / grant (A) | Common Stock | 110,436 | USD 18.11 | USD 1,999,996 | SEC filing ↗ |
| 2025-11-03 | Basso Stephen | Award / grant (A) | Common Stock | 27,609 | USD 18.11 | USD 499,999 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | INVA |
| CIK | 0001080014 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 134 transaction lines from 2020-02-03 to 2026-08-20 15 P purchase lines · 10 S sale lines · 109 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.